Walgreens Boots Alliance (WBA) Earnings Analysis

Walgreens Boots Alliance (WBA) reported results in line with expectations in FY2026 on revenue of $123.5B versus the $123.7B estimate (+15.9% YoY) and EPS of $3.21. Below is the full Walgreens Boots Alliance earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Walgreens Boots Alliance (WBA) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictIn line
Revenue$123.5B (vs $123.7B est · -0.2% surprise · +15.9% YoY)
EPS$3.21 (vs $3.25 est · -1.2% surprise · +0.4% YoY)
Share price$263.73 (+3.8%)
Market cap$2.29T

What you'll find

Frequently asked questions

When is Walgreens Boots Alliance's next earnings date?
Walgreens Boots Alliance's (WBA) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Walgreens Boots Alliance (WBA) beat or miss earnings?
In FY2026, Walgreens Boots Alliance (WBA) posted in-line results — revenue of $123.5B versus the $123.7B estimate (-0.2% surprise) and EPS of $3.21 versus $3.25 expected (-1.2% surprise). Magnisto decodes every Walgreens Boots Alliance (WBA) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Walgreens Boots Alliance (WBA) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Walgreens Boots Alliance (WBA), anchored to the current $263.73 share price, so you can weigh the bull, base and bear cases for Walgreens Boots Alliance side by side.
Is Walgreens Boots Alliance (WBA) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Walgreens Boots Alliance fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.